What this study is
This research is being done to find out more information about a brain tumor called Embryonal Tumor with Multilayer Rosettes (ETMR) by collecting medical information from children who have this disease.
The purpose of this research study is to create and maintain a research database for patients with ETMR. The database will include information about occurrence rates, patient information, tumor tissue information, and response to treatment. This will help advance our understanding of this rare disease.
In addition, this study will include obtaining survival data and evaluating therapeutic response to expert consensus therapy, and procuring patient tumor tissue.
Study details
- Sponsor
- Hackensack Meridian Health
- Conditions
- Embryonal Tumor With Multilayered Rosettes
- Enrolling
- 100 people
- Starts
- 2020-07-12
- Est. completion
- 2030-07-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients of any age
- Patients must have either a histologically confirmed primary intracranial CNS Embryonal Tumor with Multilayer Rosettes (as agreed upon by central review or local pathologist OR; Patients must have tumor tissue that possesses C19MC amplification . Central Review is not required (but is strongly recommended) if the patient's tumor does not demonstrate C19MC amplification.
- Patients may be enrolled at point following diagnosis
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openHackensack University Medical Center
Hackensack, New Jersey, United States
- Elana Smilow Smilow, MSN · Contact551-996-5673elana.smilow@HMHN.org
- Kellie Daniel, BA · Contact551-996-3654Kellie.Daniel@HMHN.org
Recruiting
Study team
Sponsor
Hackensack Meridian Health
Study ID Pro2020-0391
Principal investigator
Derek Hanson, MD
Hackensack Meridian Health
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.